Nephrogenic Systemic Fibrosis: Suspected Causative Role of Gadodiamide Used for Contrast-Enhanced Magnetic Resonance Imaging
about
Development of manganese-based nanoparticles as contrast probes for magnetic resonance imagingToxicity of MRI and CT contrast agentsNephrogenic systemic fibrosis: a survey of nephrologists' perceptions and practices.Risk for nephrogenic systemic fibrosis with gadoteridol (ProHance) in patients who are on long-term hemodialysisCardiovascular magnetic resonance physics for clinicians: Part II.New magnetic resonance imaging methods in nephrologySurface interactions with compartmentalized cellular phosphates explain rare earth oxide nanoparticle hazard and provide opportunities for safer design.Elemental and chemically specific X-ray fluorescence imaging of biological systemsNephrogenic systemic fibrosis: a concise review for cardiologists.Magnetic resonance safety.Implementation of a comprehensive MR safety course for medical students.Recurrent Syncope and Cardiac Arrest in a Patient with Systemic Light Chain Amyloidosis Treated with Bortezomib.Rare and unusual clinicopathologic presentation of renal AL amyloidosis.Renal relevant radiology: radiologic imaging in autosomal dominant polycystic kidney disease.Inorganic nanoparticles for multimodal molecular imagingMRI-detectable nanoparticles: the potential role in the diagnosis of and therapy for chronic kidney disease.Advanced MRI methods for assessment of chronic liver diseaseStaged cardiovascular magnetic resonance for differential diagnosis of troponin T positive patients with low likelihood for acute coronary syndromeComparison of concurrent complications of CKD by 2 risk categorization systems.Organic radical contrast agents for magnetic resonance imaging.Ln[DO3A-N-α-(pyrenebutanamido)propionate] complexes: optimized relaxivity and NIR optical properties.Lung Cancer-Targeting Peptides with Multi-subtype Indication for Combinational Drug Delivery and Molecular ImagingA water-soluble and water-coordinated Mn(II) complex: synthesis, characterization and phantom MRI image study.RGD-functionalized ultrasmall iron oxide nanoparticles for targeted T₁-weighted MR imaging of gliomas.Gadolinium deposition within the dentate nucleus and globus pallidus after repeated administrations of gadolinium-based contrast agents-current status.Interaction of Gd-DTPA with phosphate and phosphite: toward the reaction intermediate in nephrogenic systemic fibrosis.Quantitative measurement of blood flow in paediatric brain tumours-a comparative study of dynamic susceptibility contrast and multi time-point arterial spin labelled MRI.T1 hyperintensity on brain imaging subsequent to gadolinium-based contrast agent administration: what do we know about intracranial gadolinium deposition?Hydrochalarones: a novel endohedral metallofullerene platform for enhancing magnetic resonance imaging contrast.Non-contrast-enhanced flow-independent peripheral MR angiography with balanced SSFP.Unrecognized non-Q-wave myocardial infarction: prevalence and prognostic significance in patients with suspected coronary disease.Noncontrast-enhanced renal angiography using multiple inversion recovery and alternating TR balanced steady-state free precession.Scleroderma MimickersCollagenolytic activity is suppressed in organ-cultured human skin exposed to a gadolinium-based MRI contrast agentManaging dissections of the thoracic aorta.3D noncontrast MR angiography of the distal lower extremities using flow-sensitive dephasing (FSD)-prepared balanced SSFPNephrogenic systemic fibrosis in liver disease: a systematic review.Detection of infragenual arterial disease using non-contrast-enhanced MR angiography in patients with diabetes.Pathophysiology of nephrogenic systemic fibrosis: A review of experimental data.Quantification and Assessment of the Chemical Form of Residual Gadolinium in the Brain After Repeated Administration of Gadolinium-Based Contrast Agents: Comparative Study in Rats.
P2860
Q22064299-9E50A408-F296-4877-AC79-39DA9BF8A536Q22306013-CCE04E3C-83DC-47FB-8C70-765C082DD7CAQ24602293-DFC52D88-AC68-46AF-B9AD-CE6B4D547487Q24654124-FA2D8799-BDED-4439-8E74-4727D6693B8FQ26852691-C00F6498-707C-4B3D-B802-17EB25D6B361Q26866166-499984D3-5BB0-4994-A993-8E9624EE8E4DQ28384144-155C752A-67DD-4B58-8288-4EE0C94A6D53Q28655858-1357701C-9858-40CB-9732-74C415626A87Q28972564-949F5992-2662-4F99-BE44-E227E5001242Q30362015-A102A6FF-0E53-4334-8870-4D10A7245635Q30368767-9BDA68CD-9B04-4A7F-9822-D320048125B9Q30377076-2228770A-C6D1-46CB-805D-CD6B2CC2FB52Q30383707-41631644-8C43-49A9-A08C-3ECEF1C010D6Q30419214-5AC4414C-74A9-4288-8B70-4909C731BFD6Q30455398-B14047E6-B609-4B9C-8B9E-91B02E11B216Q30457123-09EC035D-C7EB-432E-9FB5-DB61F2245D71Q30478601-7DA3807E-9808-459A-B872-36B4C7E49BB9Q30479223-9A3FB107-A3ED-485D-BA86-B00C1AD74DE9Q30505759-6D184468-A5E3-4D16-8191-55CCCB6C239EQ30565003-7DF71369-F30B-4CA1-BCF1-DF7EC64D17A5Q30716845-CDB6B1C8-8099-4921-B23B-E6D16D72C9BDQ30851553-F0FCA034-DCAC-4C5E-AE1B-545C4AE21A22Q30978230-3ECB8378-64E0-4692-B80A-351060B6430FQ30986321-214C3B9E-A4FF-4D29-A23C-4F6E548D6159Q31045014-9018DCF9-A72B-468A-9F3C-C89CBE43F11CQ31048535-EECF3E23-EB5B-40CA-AC82-2A20D6CB11AAQ31058073-A106B319-7546-4111-AABE-CE1B3A85F6D4Q31132207-AD0B1AF8-CDA3-4B8E-B68D-56CCF51F8897Q31159392-19AB3A43-79E6-4726-885F-1C925ADEFDF5Q33430076-A1B0FBF1-5F6E-4AE2-8B73-0A56671B6266Q33432746-CDCDD146-04F4-4F7F-A3F8-C5C68E7397BCQ33574249-0DC4F320-3A59-4C22-BE80-38F6C389F2C4Q33625658-D89C2428-0A6B-4B58-BA10-076E1550784FQ33641250-32A84933-9B23-4ED0-8EB6-7C6C75B48AA0Q33669342-7CECA26E-49E4-44EA-9CE3-C5E72F0153FAQ33737384-766B3FC1-436E-4BB2-86D8-086F0A8FEBDEQ33748364-CA830FB2-336F-430A-9C62-EACDA8ABA06CQ33763791-A17C0689-A49E-40F1-8AB6-6D3F5B6965D5Q33778292-9B908EB7-3F09-45F7-A123-0DE390DBB26FQ33778968-7E4D9509-C947-4924-9301-6E81D282710D
P2860
Nephrogenic Systemic Fibrosis: Suspected Causative Role of Gadodiamide Used for Contrast-Enhanced Magnetic Resonance Imaging
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Nephrogenic Systemic Fibrosis: ...... ced Magnetic Resonance Imaging
@ast
Nephrogenic Systemic Fibrosis: ...... ced Magnetic Resonance Imaging
@en
Nephrogenic Systemic Fibrosis: ...... ced Magnetic Resonance Imaging
@en-gb
Nephrogenic Systemic Fibrosis: ...... ced Magnetic Resonance Imaging
@nl
type
label
Nephrogenic Systemic Fibrosis: ...... ced Magnetic Resonance Imaging
@ast
Nephrogenic Systemic Fibrosis: ...... ced Magnetic Resonance Imaging
@en
Nephrogenic Systemic Fibrosis: ...... ced Magnetic Resonance Imaging
@en-gb
Nephrogenic Systemic Fibrosis: ...... ced Magnetic Resonance Imaging
@nl
altLabel
Nephrogenic systemic fibrosis: ...... ced magnetic resonance imaging
@en
prefLabel
Nephrogenic Systemic Fibrosis: ...... ced Magnetic Resonance Imaging
@ast
Nephrogenic Systemic Fibrosis: ...... ced Magnetic Resonance Imaging
@en
Nephrogenic Systemic Fibrosis: ...... ced Magnetic Resonance Imaging
@en-gb
Nephrogenic Systemic Fibrosis: ...... ced Magnetic Resonance Imaging
@nl
P3181
P356
P1476
Nephrogenic Systemic Fibrosis: ...... ced Magnetic Resonance Imaging
@en
P2093
P. Marckmann
P304
P3181
P356
10.1681/ASN.2006060601
P407
P577
2006-08-09T00:00:00Z